We did not directly discriminate between the relative contributions of theseCD8+ subtypes; however, a key role for CD8+ immune cells inCOX-2-mediated control of tumor immune function is strongly supported by the restorationof NAF COX-2KD tumor cell growth in CD8+-depleted mice. This evidence concerns the gene CD8A and neoplasm.